Market Tracker

10/24 6:05pm ET

Actavis PLC (NYSE:ACT)

240.33
Data as of Oct 24
 +3.12 / +1.32%
Today’s Change
144.91
Today|||52-Week Range
249.94
+43.05%
Year-to-Date

Today’s Trading

Previous close237.21
Today’s open237.16
Day’s range236.19 - 240.85
Volume1,363,235
Average volume (3 months)2,431,516
Market cap$63.5B
Dividend yield--
Data as of 4:03pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)-793.42%
Earnings growth (this year)+39.96%
Earnings growth (next 5 years)+18.43%
Revenue growth (last year)+46.71%
P/E ratioNM
Price/Sales2.75
Price/Book4.39

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories+0.03+0.07%
AGNAllergan Inc+0.84+0.46%
LLYEli Lilly and Co+1.70+2.64%
CELGCelgene Corp+2.84+2.83%
Data as of 4:03pm ET, 10/24/2014

Financials

Next reporting dateNovember 5, 2014
EPS forecast (this quarter)$3.10
Annual revenue (last year)$8.7B
Annual profit (last year)-$750.4M
Net profit margin-8.65%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts